Jump to content


Attention Northern California Patients on Dasatinib

  • Please log in to reply
1 reply to this topic

#1 BethG


    New Member

  • Members
  • Pip
  • 4 posts

Posted 06 August 2014 - 06:34 PM

Dr. Shah at UCSF is enrolling patients for a stop dasatinib study. If you are interested, please contact study coordinator Anna Arauz at ArauzA@cc.ucsf.edu. Some parameters for the study: "They must have been treated with dasatinib for at least two years, and in a dasatinib-induced complete molecular response for at least nine months.  They cannot have had more than one prior TKI, and cannot have been treated with prior stem cell transplantation.  Additionally, they cannot have ever had accelerated or blast phase CML."
I'm just helping to spread the word! Feel free to forward as appropriate.

#2 gerry


    Advanced Member

  • Members
  • PipPipPip
  • 1,035 posts

Posted 06 August 2014 - 07:15 PM

Interesting that the trial is nine months of CMR. Be great if the second generation of TKI has shortened the waiting period. 

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users